Investment pitches
- 1.75
- Author added SOLS after volatility, arguing its chemical-stock classification obscures nuclear and AI exposure.
- Its US UF6-refining monopoly could gain pricing power as Russian HALEU imports face a 2027 ban: higher-priced contracts are rolling in, while expanded HALEU capacity may make UF6 the bottleneck.
- The HFO refrigerant duopoly is still ramping; RAS EBITDA margin expanded 740bp q/q, supporting higher peak margins than HFC.
- Sputtering targets and immersion cooling add AI exposure; author expects near-20% EBITDA growth this year and sees early-June’s nuclear investor day as a catalyst, but calls it a long-term, moderate-size position.